We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$332M
AUM Growth
+$142M
Cap. Flow
+$119M
Cap. Flow %
35.99%
Top 10 Hldgs %
4.82%
Holding
913
New
440
Increased
113
Reduced
66
Closed
294

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$1.7M
2
SLB icon
SLB Ltd
SLB
+$1.68M
3
DAY
Dayforce
DAY
+$1.59M
4
IDA icon
Idacorp
IDA
+$1.58M
5
V icon
Visa
V
+$1.49M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$968K
2
ADM icon
Archer Daniels Midland
ADM
+$967K
3
HCA icon
HCA Healthcare
HCA
+$966K
4
ABT icon
Abbott
ABT
+$966K
5
SPGI icon
S&P Global
SPGI
+$965K

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 14.71%
3 Industrials 14.47%
4 Consumer Discretionary 11.29%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCRI icon
176
Monarch Casino & Resort
MCRI
$2.21B
$630K 0.19%
+9,113
New +$580K
VRSN icon
177
VeriSign
VRSN
$25.3B
$627K 0.19%
3,042
-198
-6% -$41.2K
JBLU icon
178
JetBlue
JBLU
$1.98B
$625K 0.19%
+112,581
New +$528K
PGRE
179
DELISTED
Paramount Group
PGRE
$624K 0.19%
+120,771
New +$573K
KWR icon
180
Quaker Houghton
KWR
$2.66B
$622K 0.19%
+2,916
New +$502K
SMCI icon
181
Super Micro Computer
SMCI
$17.7B
$621K 0.19%
+21,830
New +$605K
MC icon
182
Moelis & Co
MC
$4.99B
$620K 0.19%
+11,045
New +$519K
BKR icon
183
Baker Hughes
BKR
$59.5B
$619K 0.19%
18,096
+5,552
+44% +$189K
ITCI
184
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$618K 0.19%
8,631
+2,166
+34% +$125K
UGI icon
185
UGI
UGI
$8.02B
$617K 0.19%
+25,074
New +$553K
NUVL
186
DELISTED
Nuvalent
NUVL
$614K 0.19%
+8,349
New +$517K
ROG icon
187
Rogers Corp
ROG
$2.22B
$613K 0.18%
+4,638
New +$594K
CHTR icon
188
Charter Communications
CHTR
$16.3B
$611K 0.18%
+1,572
New +$641K
NXRT
189
NexPoint Residential Trust
NXRT
$682M
$609K 0.18%
+17,699
New +$553K
ALG icon
190
Alamo Group
ALG
$2.03B
$608K 0.18%
2,892
+1,042
+56% +$191K
APD icon
191
Air Products & Chemicals
APD
$66.2B
$608K 0.18%
+2,220
New +$610K
DOCS icon
192
Doximity
DOCS
$3.8B
$606K 0.18%
+21,601
New +$510K
C icon
193
Citigroup
C
$220B
$604K 0.18%
+11,742
New +$520K
RMBS icon
194
Rambus
RMBS
$9.62B
$603K 0.18%
+8,831
New +$550K
MATV icon
195
Mativ Holdings
MATV
$476M
$601K 0.18%
39,273
+17,531
+81% +$237K
SHC icon
196
Sotera Health
SHC
$5.06B
$601K 0.18%
+35,660
New +$505K
BMBL icon
197
Bumble
BMBL
$385M
$601K 0.18%
+40,760
New +$578K
MATX icon
198
Matsons
MATX
$6.14B
$598K 0.18%
+5,459
New +$518K
BBSI icon
199
Barrett Business Services
BBSI
$1.02B
$598K 0.18%
+20,644
New +$532K
SSTK icon
200
Shutterstock
SSTK
$219M
$596K 0.18%
12,349
+6,532
+112% +$276K
6 7
8
9 10

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q4 2023 Portfolio in Review

As of Q4 2023, Nebula Research & Development held 913 positions worth $332M, up 75% from $190M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Nebula Research & Development deployed $119M of net new capital in Q4 2023, opening 440 new positions and adding to 113 existing holdings. Its largest new stake was Humana: 3,439 shares worth $1.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Hanesbrands, an estimated $775K trimmed.

  • Nebula Research & Development's largest Q4 2023 buy was Humana: 3,439 shares worth $1.57M.
  • Nebula Research & Development added most to AppFolio in Q4 2023, an estimated $1.43M increase.
  • Nebula Research & Development's biggest Q4 2023 reduction was Hanesbrands, cutting an estimated $775K.
  • Nebula Research & Development fully exited Intuit in Q4 2023, selling an estimated $968K.
  • Nebula Research & Development's ten largest holdings make up 4.8% of its $332M portfolio in Q4 2023.
  • Nebula Research & Development opened 440 new positions and closed 294 in Q4 2023.
  • Nebula Research & Development's portfolio value rose 75% quarter-over-quarter to $332M.

Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.